Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA02
- Pharmacological subgroupA02B
- Chemical subgroupA02BC
- Chemical substanceA02BC05Esomeprazole
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 132 registrations
- AXIAGO 20 mg COMPRIMIDOS GASTRORRESISTENTES20 mg · comprimido gastrorresistente · Grünenthal Pharma S.A.
- AXIAGO 40 mg COMPRIMIDOS GASTRORRESISTENTES40 mg · comprimido gastrorresistente · Grünenthal Pharma S.A.
- Emanera 20 MG Cápsulas Duras Gastrorresistentes Efg20,645 mg · cápsula dura gastrorresistente · Krka D.D. Novo Mesto
- Emanera 40 MG Cápsulas Duras Gastrorresistentes Efg41,29 mg · cápsula gastrorresistente · Krka D.D. Novo Mesto
Netherlands
CBG-MEB · 70 registrations
At a glance
- ATC code
- A02BC05
- ATC group
- Alimentary tract and metabolism
- Registers
- 9
- Historical lists
- 3
- Registrations
- 416
- With their own page
- 326
- Companies
- 144
All medicines with Esomeprazole
Human medicines from every register that match Esomeprazole by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
430 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Jamp Pharma Corporation |
| Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Sivem Pharmaceuticals Ulc |
| Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Pro Doc Limitee |
| Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Pro Doc Limitee |
| Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Sivem Pharmaceuticals Ulc |
| Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Jamp Pharma Corporation |
| Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Authorised | Ethypharm INC |
| Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Authorised | Ethypharm INC |
| Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Not marketed | Sanis Health INC |
| Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Not marketed | Sanis Health INC |
| Esomeprazole Sodium | United States | 20MG BASE/VIAL, 40MG BASE/VIAL | injectable | Marketed | Eugia Pharma |
| Esomeprazole Magnesium | United States | 20MG BASE, 40MG BASE | capsule, delayed rel pellets | Marketed | Zydus Pharms |
| Esomeprazole Magnesium | United States | 20MG BASE | tablet, delayed release | Marketed | P and L |
| Esomeprazole Magnesium | United States | 20MG BASE | capsule, delayed release | Marketed | DR Reddys |
| Esomeprazole Magnesium | United States | 10MG BASE/PACKET, 2.5MG BASE/PACKET, 20MG BASE/PACKET … | for suspension, delayed release | Marketed | Aurobindo Pharma LTD |
| Esomeprazole Magnesium | United States | 20MG BASE | tablet, orally disintegrating, delayed release | Not marketed | Dexcel |
| M-Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Mantra Pharma INC |
| M-Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Mantra Pharma INC |
| Apo-Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Apotex INC |
| Apo-Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Apotex INC |
| Myl-Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Mylan Pharmaceuticals Ulc |
| Myl-Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Mylan Pharmaceuticals Ulc |
| Riva-Esomeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Laboratoire Riva INC. |
| Riva-Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Laboratoire Riva INC. |
| Taro-Esomeprazole | Canada | 40 MG | Tablet (Delayed-Release) | Marketed | Sun Pharma Canada INC |